Form4insider filings, from the source

SEC Form 4 · accession 0000903423-17-000252

Evolent Health, Inc. · EVH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Mar 31, 2017
Accepted (ET)
Apr 4, 2017 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628908

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockF2,F3,F4,F5,F6,F7,F8Mar 31, 2017C2,113,488—A3,811,788ISee Explanation of Responses
Class A Common StockF4,F5,F6,F7,F8Mar 31, 2017S2,498,750$19.53D1,313,038ISee Explanation of Responses

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Class B Units and Class B Common StockF1,F2,F3,F5,F6,F7,F8—Mar 31, 2017C2,113,488D——Class A Common Stock2,113,4887,203,133I

Explanation of responses

Remarks

(9) The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act. (10) Clive Bode is signing on behalf of both Messrs. Bonderman and Coulter pursuant to authorization and designation letters dated June 19, 2015, which were previously filed with the Securities and Exchange Commission.